AMICUS THERAPEUTICS, INC. Deferred Tax Assets, Valuation Allowance
AMICUS THERAPEUTICS, INC. had Deferred Tax Assets, Valuation Allowance of $622.08 million as of 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-02-20
- 2025-12-31: Deferred Tax Assets, Valuation Allowance $622.08M.
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $609.13M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $649.25M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $632.23M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2025-12-31 | $622.08M 10-K · filed 2026-02-20 | |
| 2024-12-31 | $609.13M 10-K · filed 2026-02-20 | |
| 2023-12-31 | $649.25M 10-K · filed 2025-02-19 | |
| 2022-12-31 | $632.23M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $581.84M 10-K · filed 2023-03-01 | |
| 2020-12-31 | $528.89M 10-K · filed 2022-02-24 | |
| 2019-12-31 | $466.36M 10-K · filed 2021-03-01 | |
| 2018-12-31 | $363.00M 10-K · filed 2020-03-02 | |
| 2017-12-31 | $270.55M 10-K · filed 2019-02-28 | |
| 2016-12-31 | $256.96M 10-K · filed 2018-03-01 | $286.86M 10-K · filed 2017-03-01 |
| 2015-12-31 | $213.73M 10-K/A · filed 2017-03-03 | |
| 2014-12-31 | $148.44M 10-K · filed 2016-02-29 | |
| 2013-12-31 | $121.58M 10-K · filed 2015-03-03 | |
| 2012-12-31 | $95.33M 10-K · filed 2014-03-03 | |
| 2011-12-31 | $75.20M 10-K · filed 2013-03-13 |